טוען...
Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
Itraconazole, a common triazole anti-fungal drug in widespread clinical use, has evidence of clinical activity that is of interest in oncology. There is evidence that at the clinically relevant doses, itraconazole has potent anti-angiogenic activity, and that it can inhibit the Hedgehog signalling p...
שמור ב:
| הוצא לאור ב: | Ecancermedicalscience |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cancer Intelligence
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406527/ https://ncbi.nlm.nih.gov/pubmed/25932045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.521 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|